Hangzhou-based biotechnology company founded in late 2017, developing and providing precision screening products and related services for common cancers
Hangzhou-based biotechnology company founded in late 2017, developing and providing precision screening products and related services for common cancers. It focuses on early diagnosis of urologic cancers, including prostate cancer, and develops and manufactures in-vitro diagnostic reagents.